tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EWTX Stock Latest News

Edgewise Therapeutics Appoints Christopher Martin to Board
Company AnnouncementsEdgewise Therapeutics Appoints Christopher Martin to Board
21d ago
8K
EWTX
Edgewise Therapeutics price target raised to $34 from $33 at JPMorgan
PremiumThe Fly
Edgewise Therapeutics price target raised to $34 from $33 at JPMorgan
27d ago
EWTX
Edgewise Therapeutics Appoints New Chief Financial Officer
PremiumCompany Announcements
Edgewise Therapeutics Appoints New Chief Financial Officer
1M ago
8K
EWTX
Edgewise Therapeutics CFO Michael Carruthers to retire, Michael Nofi to succeed
PremiumThe Fly
Edgewise Therapeutics CFO Michael Carruthers to retire, Michael Nofi to succeed
1M ago
EWTX
Edgewise Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Edgewise Therapeutics Reports Q3 2025 Financial Results
1M ago
EWTX
Edgewise Therapeutics reports Q3 EPS (39c), consensus (40c)
PremiumThe FlyEdgewise Therapeutics reports Q3 EPS (39c), consensus (40c)
1M ago
EWTX
Edgewise Therapeutics price target raised to $33 from $30 at JPMorgan
Premium
The Fly
Edgewise Therapeutics price target raised to $33 from $30 at JPMorgan
1M ago
EWTX
Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400
Premium
Company Announcements
Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400
2M ago
EWTX
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study
PremiumCompany Announcements
Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study
2M ago
EWTX
MEDP
Edgewise Therapeutics Advances EDG-7500 Study for Hypertrophic Cardiomyopathy
PremiumCompany Announcements
Edgewise Therapeutics Advances EDG-7500 Study for Hypertrophic Cardiomyopathy
2M ago
EWTX
Edgewise Therapeutics’ EDG-7500 Study: A Potential Game Changer for Renal Impairment Treatment?
PremiumCompany Announcements
Edgewise Therapeutics’ EDG-7500 Study: A Potential Game Changer for Renal Impairment Treatment?
2M ago
EWTX
Promising Developments in Edgewise Therapeutics’ Sevasemten for Becker Muscular Dystrophy Earns Buy Rating
PremiumRatings
Promising Developments in Edgewise Therapeutics’ Sevasemten for Becker Muscular Dystrophy Earns Buy Rating
2M ago
EWTX
Cautious Neutral Rating for Edgewise Therapeutics Amid Clinical and Regulatory Uncertainties
PremiumRatingsCautious Neutral Rating for Edgewise Therapeutics Amid Clinical and Regulatory Uncertainties
3M ago
EWTX
Goldman Sachs assigns Neutral rating to Edgewise Therapeutics
Premium
The Fly
Goldman Sachs assigns Neutral rating to Edgewise Therapeutics
3M ago
EWTX
Edgewise Therapeutics downgraded to Neutral from Buy at Goldman Sachs
Premium
The Fly
Edgewise Therapeutics downgraded to Neutral from Buy at Goldman Sachs
3M ago
EWTX
JPMorgan cuts Edgewise target, remains from Analyst Focus List
PremiumThe Fly
JPMorgan cuts Edgewise target, remains from Analyst Focus List
4M ago
EWTX
Edgewise Therapeutics Advances in Muscular Dystrophy Trials
PremiumCompany Announcements
Edgewise Therapeutics Advances in Muscular Dystrophy Trials
4M ago
EWTX
Edgewise Therapeutics: Strong Financial Health and Promising Clinical Advances Drive Buy Rating
PremiumRatings
Edgewise Therapeutics: Strong Financial Health and Promising Clinical Advances Drive Buy Rating
4M ago
EWTX
Edgewise Therapeutics reports Q2 EPS (34c), consensus (42c)
PremiumThe Fly
Edgewise Therapeutics reports Q2 EPS (34c), consensus (42c)
4M ago
EWTX
Peloton upgraded, Booking downgraded: Wall Street’s top analyst calls
PremiumThe FlyPeloton upgraded, Booking downgraded: Wall Street’s top analyst calls
4M ago
BX
ALB
3 Best Stocks to Buy Now, 7/30/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/30/2025, According to Top Analysts
4M ago
HUT
BTDR
Edgewise Therapeutics initiated with a Strong Buy at Raymond James
Premium
The Fly
Edgewise Therapeutics initiated with a Strong Buy at Raymond James
5M ago
EWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >